Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Esperion Therapeutics Inc (NASDAQ:ESPR)

52.51
Delayed Data
As of Aug 28
 +0.50 / +0.96%
Today’s Change
15.00
Today|||52-Week Range
120.96
+29.85%
Year-to-Date

Today’s Trading

Previous close52.01
Today’s open52.52
Day’s range51.68 - 55.23
Volume1,096,806
Average volume (3 months)1,339,813
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+32.93%
Earnings growth (this year)-9.62%
Earnings growth (next 5 years)-21.89%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book8.00

Competitors

 Today’s
change
Today’s
% change
AXONAxovant Sciences Ltd-0.60-4.81%
ATRAAtara Biotherapeutic...+0.25+0.63%
IMGNImmunoGen Inc0.000.00%
CHRSCoherus BioSciences ...+0.44+1.54%
Data as of 4:01pm ET, 08/28/2015

Financials

Next reporting dateNovember 4, 2015
EPS forecast (this quarter)-$0.61
Annual revenue (last year)$0.00
Annual profit (last year)-$36.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Scientific Officer
Roger S. Newton
President, Chief Executive Officer &
Director
Tim M. Mayleben
Corporate headquarters
Ann Arbor, Michigan

Forecasts

Partner Offers